3653 results for «302»
3653 results
Gulf WIN - Opportunities and challenges
15 Dec 2022 – From GulfPCR-GIM 2022
Women have the floor in this special GulfPCR-GIM 2022 session: hear from members of the Gulf WIN (Women In Intervention) to better understand the status of women interventionists in the region, explore the challenges they face, and note the differences that exist with other women cardiologists...
Optimal management of a patient with calcified lesions - Session with LIVE case
15 Dec 2022 – From GulfPCR-GIM 2022
Watch the case of an 87-year-old male patient with DM, HTN, and hyperlipidemia, who suffered ACS six weeks ago, whose culprit lesions were treated in the RCA and LCX, and who was incidentally readmitted for LAD PCI, and find out how he was treated LIVE.
Essential drugs that every interventionalist needs to know
15 Dec 2022 – From GulfPCR-GIM 2022
In this GulfPCR-GIM 2022 session, learn about the role of PCSK9 inhibitors in ACS and post-PCI patients, the role of SGLT2 receptor blockers and GLP RAs, and the role of P2Y12 inhibitors as unique post-PCI antiplatelet agents.
Severe mitral and tricuspid regurgitation
15 Dec 2022 – From GulfPCR-GIM 2022
This GulfPCR-GIM 2022 session aims to illustrate the role of mitral TEER in patients with significant MR and cardiogenic shock, to demonstrate the importance of early detection, but also to show that earlier referral and treatment of patients with significant TR is essential to prevent patients...
Imaging for tricuspid valve interventions
17 Feb 2023 – From PCR Tokyo Valves 2023
After reviewing the anatomy of the tricuspid valve, learn, in this PCR Tokyo Valves 2023 session on this specific valve, how to evaluate it with trans-oesophageal echocardiography, how to classify TR, what the pitfalls are, and tips and tricks for intra-procedural imaging.
Imaging for aortic valve interventions
17 Feb 2023 – From PCR Tokyo Valves 2023
In this session, review the anatomy of the aortic valve system, learn how to assess low-flow, low-gradient severe AS, identify the pitfalls to avoid when assessing paravalvular leakage after TAVI, and find out more about how to detect valve thrombosis and degeneration, among others!
Imaging for mitral valve interventions
17 Feb 2023 – From PCR Tokyo Valves 2023
Watch this PCR Tokyo Valves 2023 session to review the anatomy of the mitral valve, learn how to assess it with a trans-oesophageal echocardiography, find out how to grade MR and avoid its pitfalls, and get tips and tricks for successful intraprocedural TEE.
TAVI with advanced imaging techniques - LIVE case
18 Feb 2023 – From PCR Tokyo Valves 2023
A 93-year-old female, with chronic kidney disease (GFR:34), diabetes, first degree AV block, present a symptomatic severe calcified aortic stenosis. Watch the operators as they implant an Evolut pro 26mm, guided by ICE in order to check the position of the distal part of the valve with...
Efficacy and safety of Edoxaban in anticoagulant therapy early after surgical bioprosthetic valve replacement: ENBALV trial
16 Nov 2024
Edoardo Zancanaro provides his take on the ENBALV trial presented by Chisato Izumi at AHA 2024 in Chicago.
Author
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial
05 Mar 2023
Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).
Author
Transcatheter edge-to-edge repair of functional mitral regurgitation in heart failure: Final five-year results from the COAPT Trial
06 Mar 2023
Alex Sticchi & Jonathan Curio provide their take on the clinical trial presented by Gregg W. Stone at the American College of Cardiology Scientific Sessions (ACC.23/WCC).
Author
Author
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
31 Aug 2021
Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.
Author
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
29 Mar 2025
Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.
Author
Author
